Presentation is loading. Please wait.

Presentation is loading. Please wait.

Effect of omalizumab in health care workers with occupational latex allergy  Francisque Leynadier, MD, Ouafia Doudou, MD, Hafida Gaouar, MD, Vincent Le.

Published byHarjanti Darmali Modified over 6 years ago

Similar presentations

Presentation on theme: "Effect of omalizumab in health care workers with occupational latex allergy  Francisque Leynadier, MD, Ouafia Doudou, MD, Hafida Gaouar, MD, Vincent Le."— Presentation transcript:

1 Effect of omalizumab in health care workers with occupational latex allergy 
Francisque Leynadier, MD, Ouafia Doudou, MD, Hafida Gaouar, MD, Vincent Le Gros, MD, Isabelle Bourdeix, PhD, Laurence Guyomarch-Cocco, BS, Patrick Trunet, MD  Journal of Allergy and Clinical Immunology  Volume 113, Issue 2, Pages (February 2004) DOI: /j.jaci

2 FIG 1 Mean (± SEM) total score of the conjunctival challenge test during double-blind treatment with omalizumab or placebo, followed by open-label treatment with omalizumab (all subjects), for latex allergy in health care workers. ∗∗P < .01 and ∗∗∗P < .001 versus placebo (Wilcoxon rank sum test). Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )

Download ppt "Effect of omalizumab in health care workers with occupational latex allergy  Francisque Leynadier, MD, Ouafia Doudou, MD, Hafida Gaouar, MD, Vincent Le."

Similar presentations

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema– dermatitis syndrome  Mirva Viljanen, MD, Emma Pohjavuori, MD, Tari.

Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema– dermatitis syndrome  Mirva Viljanen, MD, Emma Pohjavuori, MD, Tari.
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Clarification concerning amoxicillin skin testing

Clarification concerning amoxicillin skin testing
The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria  Marcus Maurer, MD, Allen Kaplan, MD, Karin Rosén, MD, PhD, Michael Holden,

The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria  Marcus Maurer, MD, Allen Kaplan, MD, Karin Rosén, MD, PhD, Michael Holden,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect  Peter D. Sly, MD, DSc, Julie Varghese, BHMS, PGDCTM,

Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect  Peter D. Sly, MD, DSc, Julie Varghese, BHMS, PGDCTM,
Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled.

Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled.
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Disaggregating asthma: Big investigation versus big data

Disaggregating asthma: Big investigation versus big data
Practice Notes from the AAAI

Practice Notes from the AAAI
Serum periostin is associated with type 2 immunity in severe asthma

Serum periostin is associated with type 2 immunity in severe asthma
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Allergy testing in predicting outcome of open food challenge to peanut

Allergy testing in predicting outcome of open food challenge to peanut
A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy  Justin M. Skripak, MD, Scott D. Nash, MD, Hannah.

A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy  Justin M. Skripak, MD, Scott D. Nash, MD, Hannah.
Reply Journal of Allergy and Clinical Immunology

Reply Journal of Allergy and Clinical Immunology
Treatment of chronic autoimmune urticaria with omalizumab

Treatment of chronic autoimmune urticaria with omalizumab
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria 

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria 
Combating high-priority biological agents

Combating high-priority biological agents

Similar presentations

Ads by Google